| Willow Tree Counseling Llc | |
|
128 Plaza Cir Waterloo IA 50701-5139 | |
| (319) 533-5707 | |
| Not Available |
| Full Name | Willow Tree Counseling Llc |
|---|---|
| Speciality | Counselor |
| Location | 128 Plaza Cir, Waterloo, Iowa |
| Authorized Official Name and Position | Lisa Barron (OWNER) |
| Authorized Official Contact | 3195335707 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Willow Tree Counseling Llc 128 Plaza Cir Waterloo IA 50701-5139 Ph: (319) 533-5707 | Willow Tree Counseling Llc 128 Plaza Cir Waterloo IA 50701-5139 Ph: (319) 533-5707 |
| NPI Number | 1780455386 |
|---|---|
| Provider Enumeration Date | 01/11/2024 |
| Last Update Date | 01/11/2024 |
| Certification Date | 01/11/2024 |
| Medicare PECOS PAC ID | 6608210265 |
|---|---|
| Medicare Enrollment ID | O20240222001124 |
News Archive
Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center.
With research and development assistance from the Georgia Tech Research Institute (GTRI) and seed funding from the Georgia Research Alliance (GRA), an Atlanta-based company is developing what it hopes will be the next-generation instrument for optimizing eyesight for the hundreds of millions of people who wear glasses or contacts - or who are candidates for corrective surgery.
Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.
Many surgeons contract informally with patients preoperatively about the use of postoperative life support, report researchers.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 5 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780455386 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Lisa Lmhc Barron |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1740656875 PECOS PAC ID: 3678919842 Enrollment ID: I20240311000710 |
News Archive
Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center.
With research and development assistance from the Georgia Tech Research Institute (GTRI) and seed funding from the Georgia Research Alliance (GRA), an Atlanta-based company is developing what it hopes will be the next-generation instrument for optimizing eyesight for the hundreds of millions of people who wear glasses or contacts - or who are candidates for corrective surgery.
Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.
Many surgeons contract informally with patients preoperatively about the use of postoperative life support, report researchers.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 5 days ago
News Archive
Terminally ill rodents with type 1 diabetes have been restored to full health with a single injection of a substance other than insulin by scientists at UT Southwestern Medical Center.
With research and development assistance from the Georgia Tech Research Institute (GTRI) and seed funding from the Georgia Research Alliance (GRA), an Atlanta-based company is developing what it hopes will be the next-generation instrument for optimizing eyesight for the hundreds of millions of people who wear glasses or contacts - or who are candidates for corrective surgery.
Inovio Pharmaceuticals, Inc. today unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.
Many surgeons contract informally with patients preoperatively about the use of postoperative life support, report researchers.
New findings presented today during the APASL Liver Week in Singapore, highlighted the efficacy and safety of faldaprevir+ plus pegylated interferon and ribavirin (PegIFN/RBV) in treatment-naïve patients with genotype-1 hepatitis C virus (HCV) in Asia.1 This post-hoc sub-analysis of the Phase III STARTVerso™1 and 2 trials showed that both doses of faldaprevir were associated with high viral cure rates and a shorter treatment duration in this particular patient group.1
› Verified 5 days ago
Pathways Behavioral Services, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3362 University Ave, Waterloo, IA 50701 Phone: 319-235-6571 Fax: 319-235-6028 | |
New Start Behavioral Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 212 E 4th Street,, Waterloo, IA 50703 Phone: 319-493-5120 | |
Cedar Valley Center For Expressive Arts Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 905 Sycamore St, Waterloo, IA 50703 Phone: 319-888-1022 | |
Veridian Fiscal Solutions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 233 Fisher Dr, Waterloo, IA 50701 Phone: 855-828-0775 | |
Veridian Fiscal Solutions Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 233 Fisher Dr, Waterloo, IA 50701 Phone: 855-828-0775 | |
Change Behavioral Health, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 501 Sycamore St Ste 623, Waterloo, IA 50703 Phone: 319-233-0323 Fax: 319-233-5923 | |
Hope Tree Counseling Services Inc. Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1420 W Donald St, Waterloo, IA 50703 Phone: 319-232-4673 |